MAPT expression was highly variable, with brain glioblastoma multiforme (GBM), lower grade glioma (LGG), and neuroendocrine (pheochromocytoma and paraganglioma, PCPG) tumors showing the highest expression followed by breast cancer (BRCA) (Fig. 1a). This evidence concerns the gene MAPT and breast cancer.